Abstract: Twenty mature horses with typical headshaking of 2 week-7 year duration were studied. Clinical examinations included radiography of the head and nasopharyngeal endoscopy. All were assessed at rest and at exercise, both before and after fitting an occlusive nasal mask, application of tinted contact lenses and the perineural anaesthesia of the infraorbital and posterior ethmoidal branches of the trigeminal nerve. Infraorbital anaesthesia had no effect in 6/7 cases but 11/17 (65%) cases showed a 90-100% improvement following posterior ethmoidal nerve anaesthesia. Tinted contact lenses had no apparent long-term benefit, although 2 cases showed a transient improvement. We found no other evidence to suggest a photic aetiology in the current series of cases. Treatment regimens based on the results of the diagnostic investigative methods included sclerosis of the posterior ethmoidal branch of the trigeminal nerve. This was effective in some cases but the benefits were temporary. Cyproheptadine alone was ineffective but the addition of carbamazepine resulted in 80-100% improvement in 80% of cases. Carbemazepine alone was effective in 88% of cases but results were unpredictable at predefined dose rates. The positive response to carbamazepine, combined with the clinical features is consistent with involvement of the trigeminal nerve, particularly the more proximal branches such as the posterior ethmoidal nerve. Headshaking has some clinical features in common with trigeminal neuralgia in humans. As a result of the findings detailed in this paper, we conclude that a trigeminal neuritis or neuralgia may be the basis of the underlying aetiopathology of equine headshaking. Initial observations of the positive response of headshakers to carbamazepine therapy is encouraging. However, future studies will include a more detailed investigation of dosages, duration of effectiveness (in some cases it appears short-lived) and other effects. In practice there is a realistic possibility of controlling but not curing headshaking with carbamazepine therapy at the present time. Other future investigations will include details of the functional anatomy of the trigeminal nerve and the role of the P2 myelin protein in headshaking and other neurological disease.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research focuses on investigating the possible cause and treatments for headshaking in horses. It suggests that a condition similar to human trigeminal neuralgia, affecting a specific nerve in the horse’s head, may be responsible. The medication carbamazepine showed promise in managing the condition, though cure remains elusive.
Study Sample and Procedures
The research involved twenty mature horses that had been showing signs of typical headshaking between 2 weeks to 7 years period.
Each horse underwent a clinical examination, including radiography of the head and nasopharyngeal endoscopy. They were observed at rest and during exercise, both before and after several interventions.
The interventions included the application of an occlusive nasal mask, tinted contact lenses, and the perineural anaesthesia of the infraorbital and posterior ethmoidal branches of the trigeminal nerve.
Outcome of Interventions
Infraorbital anaesthesia showed no effect in the majority of cases. However, posterior ethmoidal nerve anaesthesia appeared promising, showing substantial improvement in 65% of the cases.
Tinted contact lenses demonstrated no long-term benefit, with only two cases showing a transient improvement.
The study found no evidence supporting a photic (light-based) cause of the headshaking in horses.
Treatment Success and Conclusions
Treatments were designed based on the results of the diagnostic methods. One such method was sclerosis (hardening) of the posterior ethmoidal branch of the trigeminal nerve. While this had temporary benefits, it wasn’t a definitive solution.
Medication trials with cyproheptadine and carbamazepine were conducted. Cyproheptadine alone didn’t produce any significant results. However, when combined with carbamazepine, there was noticeable improvement noted in a majority of the cases.
Carbamazepine on its own was effective in 88% of cases. However, its effectiveness was unpredictable at pre-set doses.
Based on the positive outcomes following carbamazepine treatment, and given the clinical characteristics of the headshaking, the researchers suggest the possible involvement of the trigeminal nerve in the condition.
They conclude that a condition similar to human trigeminal neuralgia might be an underlying cause of equine headshaking. They also open up avenues for further research, encompassing a detailed investigation of dosages, duration of effectiveness, and other effects of carbamazepine treatment.
Cite This Article
APA
Newton SA, Knottenbelt DC, Eldridge PR.
(2000).
Headshaking in horses: possible aetiopathogenesis suggested by the results of diagnostic tests and several treatment regimes used in 20 cases.
Equine Vet J, 32(3), 208-216.
https://doi.org/10.2746/042516400776563617